FDA Inspection 1102613 - Innovative Transfusion Medicine, Inc. - September 19, 2019

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Innovative Transfusion Medicine, Inc.

Record Details

This FDA Inspection record concerns Innovative Transfusion Medicine, Inc., with an inspection on September 19, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: Innovative Transfusion Medicine, Inc.
Inspection Date: September 19, 2019
Product Type: Biologics
Office: Center for Biologics Evaluation and Research

Open in Dashboard

ID · e3d308ba-7fe0-4922-9a79-69ad20391deb

Violation Codes5

21 CFR 606.100(b)21 CFR 606.160(b)21 CFR 606.20(b)21 CFR 606.60(a)21 CFR 630.10(h)

Full citation text and observation details available on the Dashboard.

FDA Inspection

Innovative Transfusion Medicine, Inc.September 19, 2019